External Collaboration. Research Consortium. NEPHSTROM (H2020) will examine the safety, feasibility and efficacy of ORBCEL-M� cells in Phase1b 2a dose escalation study in diabetic kidney disease, in 4 European clinical centres and coordinated by Istituto di Ricerche Farmacologiche Mario Negri (IRFMN), Bergamo, Italy.